No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials
The study is expected to begin in the first quarter of 2027 & enrol around 1,000 patients in Brazil, Malaysia & Thailand. SII is also conducting a separate Phase III trial in India.
Summary written by a Chikitsa reviewer from the source linked below.
Classification
Domain
Vector-Borne Disease
Accountability
Public exposed to a hazard
A population is exposed to preventable danger — outbreaks and surveillance failure, contamination, adulteration, pollution, antimicrobial resistance, unsafe products or premises.
Chikitsa Healthcare Signal Register. (2026). No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials (Record 100458) [Data set]. Chikitsa. Retrieved 11 November 2026, from https://chikitsa.live/signal/100458
Data collected (retrieved) 11-11-2026 20:06 IST. CC BY 4.0. Attribution required. Machine-readable: /api/cite?public_id=100458&style=apa